Cidara Therapeutics, Inc.

New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: May 6, 2024
Total Offering

$240,000,000

Amount Sold

$240,000,000

Investors

7

First Sale

Apr 24, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Jeffrey Stein, Ph.D.
Related Person
Daniel D. Burgess
Related Person
Theodore R. Schroeder
Related Person
Bonnie Bassler, Ph.D.
Related Person
Carin Canale-Theakston
Related Person
James Merson, Ph.D.
Related Person
Ryan Spencer
Related Person
Laura Tadvalkar, Ph.D.
Related Person
Taylor Sandison, M.D.
Related Person
Preetam Shah, Ph.D.
Related Person
Leslie Tari, Ph.D.
Related Person
Shane Ward
Related Person

Company

Cidara Therapeutics, Inc.

6310 NANCY RIDGE DRIVE

SAN DIEGO, CA, 92121

858-752-6170

SEC Filing

0001610618-24-000069

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free